Optimal timing of pharmacoinvasive strategy and its impact on clinical and economic outcomes in patients with ST-elevation myocardial infarction: a real-world perspective

Optimal timing of pharmacoinvasive strategy and its impact on clinical and economic outcomes in patients with ST-elevation myocardial infarction: a real-world perspective

BackgroundThe pharmacoinvasive (PhI) strategy is the standard-of-care for ST-elevation myocardial infarction (STEMI) patients when primary percutaneous coronary intervention (pPCI) is unfeasible. Optimal timing for post-fibrinolytic PCI (lysis-PCI) remains elusive. Therefore, this study aimed to ass...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrea Dias Stephanus, Alice Pacheco Santos, Ana Carolina Machado Rodrigues da Cunha, Ana Carolina Augusto Rocha, Amanda de Amorim Meireles, Mariana Guimarães Souza de Oliveira, Pietra Arissa Coelho Matsunaga, Alexandre Anderson de Sousa Munhoz Soares, Ana Claudia Cavalcante Nogueira, Adriana de J. B. de Almeida Guimarães, Gustavo de Almeida Alexim, Alessandra M. Campos-Staffico, Luiz Sergio Fernandes de Carvalho
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
ST-segment elevation myocardial infarction
fibrinolysis
percutaneous coronary intervention
pharmacoinvasive strategy
reperfusion strategy
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2024.1466961/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2024.1466961/full

Similar Items